MTEM: Multiplikator Forward P/S Molecular Templates Inc

Molecular Templates faces serious challenges, including frequent research pauses due to drug toxicity and a rapid cash burn rate. The firm's forward P/S reflects the impact of rising costs on asset valuation, where the 0.00 mark indicates the current state. The business is currently seeking a buyer for its patents, while simultaneously implementing green technologies and water filtration systems in its laboratories.

MTEM Molecular Templates, Inc.: Rasio kapitalisasi pasar marang pendapatan mangsa ngarep ing interval 04.07.2022 - 28.12.2024

Ringkesan rincian data analitis Molecular Templates Corporation (MTEM)

- rega saham lan target rega konsensus:

Kutipan saham Molecular Templates, Inc.|MTEM - Rega prakiraan analis

- informasi kapitalisasi pasar:

Kapitalisasi pasar Molecular Templates Corporation|MTEM - Nilai Wutuh Bisnis

- statistik nilai buku emiten:

Aset Bersih saben Siji Saham Molecular Templates|MTEM - Ekuitas Perusahaan|Rasio Nilai Pasar marang Nilai Buku mtem.com|MTEM - Nilai Agregat Aset

- indikator beban utang lan likuiditas:

Utang marang Ekuitas Molecular Templates|MTEM - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Molecular Templates|MTEM - Gunggung kewajiban utang perusahaan|Rasio utang marang kapitalisasi buku Molecular Templates Corporation|MTEM - Kewajiban jangka dawa perusahaan|Utang jangka cendhak perusahaan Molecular Templates|Likuiditas cepet mtem.com

- data bathi bisnis lan rasio investasi:

MTEM - Bathi resik perusahaan|Proyeksi bathi mangsa ngarep Molecular Templates|MTEM - Kapitalisasi marang bathi|Pangali Forward P/E Molecular Templates Corp|MTEM - Pangali rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Molecular Templates Corporation|MTEM - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan Molecular Templates|MTEM - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi EPS kuartalan mtem.com|MTEM - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Molecular Templates

- rincian pendapatan lan dodolan:

MTEM - Pendapatan dodolan perusahaan|Volume dodolan mangsa ngarep perusahaan Molecular Templates, Inc.|MTEM - Rasio kapitalisasi pasar marang pendapatan|Multiplikator forward rega marang pendapatan Molecular Templates Corporation

Analisis komprehensif perusahaan:MTEM (Molecular Templates, Inc.)

The forward P/S filters out market noise and short-term liquidity spikes by measuring the ratio of market capitalization to expected revenue to assess the fundamental overbought status of an asset. For Molecular Templates (MTEM), which is developing an engineered toxin platform, the company's forward P/S chart reflects market expectations for the commercialization of targeted drugs, making it possible to determine how sustainable the current capital valuation is against potential multiple compression.

Pesaing Molecular Templates (MTEM)

Geron - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake NBTX (Nanobiotix SA)|Bicycle Pharma - Multiplikator Forward P/S|Rega mangsa ngarep marang pendapatan CTMX|perspectivetherapeutics.com (CATX) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Genelux (GNLX)|Rasio rega marang prakiraan pendapatan Molecular Partners|ONCY: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Lisata Therapeutics (LSTA)|Multiplikator forward rega marang pendapatan moleculin.com MBRX|Rasio rega marang prakiraan pendapatan Galera Therapeutics, Inc. GRTX